One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?
Asaf Levartovsky, Shomron Ben-Horin
doi : 10.1093/ecco-jcc/jjab167
Journal of Crohn's and Colitis, Volume 16, Issue 4, April 2022, Pages 517–518
A TIGER Among Endoscopic Indices in Inflammatory Bowel Disease
Jurij Hanzel, Vipul Jairath
doi : 10.1093/ecco-jcc/jjab235
No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound
Gerhard Rogler
doi : 10.1093/ecco-jcc/jjab220
ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease
Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jordi Rimola
doi : 10.1093/ecco-jcc/jjab180
The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn’s Disease and Ulcerative Colitis Patients
E Zittan, A H Steinhart, H Aran, R Milgrom, I M Gralnek, S Zelber-Sagi, M S Silverberg
doi : 10.1093/ecco-jcc/jjab122
Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement
Johan F K F Ilvemark, Tawnya Hansen, Thomas M Goodsall, Jakob B Seidelin, Heba Al- Farhan, Mariangela Allocca, Jakob Begun, Robert V Bryant, Dan Carter, Britt Christensen, Marla C Dubinsky, Krisztina B Gecse, Torsten Kucharzik, Cathy Lu, Christian Maaser, Giovanni Maconi, Kim Nylund, Carolina Palmela, Stephanie R Wilson, Kerri Novak, Rune Wilkens
doi : 10.1093/ecco-jcc/jjab173
Inflammatory Bowel Disease-related Behaviours [IBD-Bx] Questionnaire: Development, Validation and Prospective Associations with Fatigue
Marta Walentynowicz, Iris van de Pavert, Liselotte Fierens, Sofie Coenen, Johan W S Vlaeyen, Andreas von Leupoldt, Lukas Van Oudenhove, Séverine Vermeire, Gert Van Assche, Marc Ferrante, Ilse Van Diest
doi : 10.1093/ecco-jcc/jjab174
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Amanda Ricciuto, Christopher A Lamb, Eric I Benchimol, Gareth J Walker, Nicholas A Kennedy, M Ellen Kuenzig, Gilaad G Kaplan, Michael D Kappelman, Ryan C Ungaro, Jean-Frederic Colombel, Erica J Brenner, Manasi Agrawal, Walter Reinisch, Anne M Griffiths, Shaji Sebastian
doi : 10.1093/ecco-jcc/jjab172
Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn’s Disease
Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye
doi : 10.1093/ecco-jcc/jjab182
Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm
S Bots, F De Voogd, M De Jong, V Ligtvoet, M Löwenberg, M Duijvestein, C Y Ponsioen, G D’Haens, K B Gecse
doi : 10.1093/ecco-jcc/jjab175
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn’s Disease
Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, William J Sandborn, Marc Ferrante, John K Marshall, Walter Reinisch, Parambir S Dulai
doi : 10.1093/ecco-jcc/jjab183
Postpartum Surgical Complications in Women with Inflammatory Bowel Disease After Caesarian Section: A Danish Nationwide Cohort Study
Sonia Friedman, Floor Dijkstra Zegers, Line Riis Jølving, Jan Nielsen, Bente Mertz Nørgård
doi : 10.1093/ecco-jcc/jjab187
Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study
Jiao Luo, Zhongwei Xu, Raymond Noordam, Diana van Heemst, Ruifang Li-Gao
doi : 10.1093/ecco-jcc/jjab191
Crohn’s Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases
Yoichi Kakuta, Hideya Iwaki, Junji Umeno, Yosuke Kawai, Masahiro Kawahara, Tetsuya Takagawa, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Masatake Kuroha, Hisashi Shiga, Kenji Watanabe, Shiro Nakamura, Hiroshi Nakase, Makoto Sasaki, Hiroyuki Hanai, Yuta Fuyuno, Atsushi Hirano, Takayuki Matsumoto, Hisaaki Kudo, Naoko Minegishi, Minoru Nakamura, Tadakazu Hisamatsu, Akira Andoh, Masao Nagasaki, Katsushi Tokunaga, Yoshitaka Kinouchi, Atsushi Masamune, MENDEL Study Group
doi : 10.1093/ecco-jcc/jjab199
MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon
Ting-yi Sun, Ya-qi Li, Fu-qian Zhao, Hai-mei Sun, Yang Gao, Bo Wu, Shu Yang, Feng-qing Ji, De-shan Zhou
doi : 10.1093/ecco-jcc/jjab179
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y F Li Yim, Ishtu L Hageman, Jan Verhoeff, Manon de Krijger, Patricia H P van Hamersveld, Olaf Welting, Iris Admiraal, Shafaque Rahman, Juan J Garcia-Vallejo, Manon E Wildenberg, Laura Tomlinson, Richard Gregory, Inmaculada Rioja, Rab K Prinjha, Rebecca C Furze, Huw D Lewis, Palwinder K Mander, Sigrid E M Heinsbroek, Matthew J Bell, Wouter J de Jonge
doi : 10.1093/ecco-jcc/jjab176
Dietary Therapy Reduces Pro-inflammatory Microbiome Features in Paediatric Crohn’s Disease
Charlotte M Verburgt, Katherine A Dunn, Johan E Van Limbergen
doi : 10.1093/ecco-jcc/jjab197
Disseminated Tuberculosis in a Patient Treated with Tofacitinib for Ulcerative Colitis
Flora Charpy, Romain Altwegg, Antoine Debourdeau
doi : 10.1093/ecco-jcc/jjab200
Safety of COVID-19 Vaccination in Inflammatory Bowel Disease Patients on Biologic Therapy
Isabel Garrido, Susana Lopes, Guilherme Macedo
doi : 10.1093/ecco-jcc/jjab189
Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease
B Jójárt, T Molnà r, V Szabó, � Varga, T Resà l, K Szà ntó, D Kata, I Földesi, T Molnár, J Maléth, K Farkas
doi : 10.1093/ecco-jcc/jjab160
Personalised Medicine with IL-23 Blockers: Myth or Reality?
Zoë S Gottlieb, Bruce E Sands
doi : 10.1093/ecco-jcc/jjab190
Evolution of IL-23 Blockade in Inflammatory Bowel Disease
Silvio Danese, Laurent Peyrin-Biroulet
doi : 10.1093/ecco-jcc/jjab188
Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
Gavin W Sewell, Arthur Kaser
doi : 10.1093/ecco-jcc/jjac034
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
Mario Valenti, Alessandra Narcisi, Giulia Pavia, Luigi Gargiulo, Antonio Costanzo
doi : 10.1093/ecco-jcc/jjac023
Ustekinumab in Crohn’s Disease: New Data for Positioning in Treatment Algorithm
Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese
doi : 10.1093/ecco-jcc/jjac011
IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
Benjamin D McDonald, Emma C Dyer, David T Rubin
doi : 10.1093/ecco-jcc/jjac038
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
Raja Atreya, Markus F Neurath
doi : 10.1093/ecco-jcc/jjac007
Blockade of IL-23: What is in the Pipeline?
Tommaso Lorenzo Parigi, Marietta Iacucci, Subrata Ghosh
doi : 10.1093/ecco-jcc/jjab185
